Improvement of the closed cranial window model in rats by intracarotid infusion of signalling molecules implicated in migraine

S Gupta; D K Bhatt; L J Boni; J Olesen; S Gupta; D K Bhatt; L J Boni; J Olesen

doi:10.1111/j.1468-2982.2009.01888.x

Improvement of the closed cranial window model in rats by intracarotid infusion of signalling molecules implicated in migraine

S Gupta, D K Bhatt, L J Boni, J Olesen, S Gupta, D K Bhatt, L J Boni, J Olesen

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

24 Citationer (Scopus)

Abstract

Udgivelsesdato: 2010-Jan

Originalsprog	Engelsk
Tidsskrift	Cephalalgia
Vol/bind	30
Udgave nummer	1
Sider (fra-til)	27-36
Antal sider	10
ISSN	0333-1024
DOI	https://doi.org/10.1111/j.1468-2982.2009.01888.x https://doi.org/10.1111/j.1468-2982.2009.01888.x
Status	Udgivet - 2010

Adgang til dokumentet

Citationsformater

@article{7b5930c0d78111df825b000ea68e967b,

title = "Improvement of the closed cranial window model in rats by intracarotid infusion of signalling molecules implicated in migraine",

abstract = "Intravital microscopy on a closed cranial window allows one to measure change in the diameter of cranial blood vessels after intravenous (i.v.) administration of pharmacodynamic substances. Putative targets being pursued in migraine are large vasodilating peptide molecules such as calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase polypeptide (PACAP)-38. High i.v. doses are required to study their craniovascular pharmacology. Unfortunately, this leads to a drop in blood pressure (BP) that subsequently causes blood vessels to dilate by autoregulation. Hence it is difficult to decipher what effect is caused by direct receptor agonist interaction or contributed by autoregulation. In the present study we infused substances with an ingenious indwelling catheter in the common carotid artery in rats. Intracarotidly seven-, 12- and 17-fold lower doses of CGRP, PACAP-38 and capsaicin were required, respectively, compared with i.v. infusion to induce the same dilation in dural artery. Dilating intracarotid (i.c.) doses caused no or a minimal fall in BP, whereas equi-responsive i.v. doses caused a marked BP reduction. The CGRP blocking potential of olcegepant was amplified by > 20 times on i.c. infusion. Pial artery responses to CGRP did not change with i.c. infusion, demonstrating that dilations after i.v. CGRP are mediated by autoregulation rather than through specific receptors. We applied CGRP topically, which induced concentration-dependent dural vasodilation, but no effect on pial artery or on BP. In conclusion, this new approach offers an improvement of the existing model by allowing more accurate assessment of effects of pharmaca on the cranial vasculature without inducing significant systemic effects.",

author = "S Gupta and Bhatt, {D K} and Boni, {L J} and J Olesen and S Gupta and Bhatt, {D K} and Boni, {L J} and J Olesen",

year = "2010",

doi = "10.1111/j.1468-2982.2009.01888.x",

language = "English",

volume = "30",

pages = "27--36",

journal = "Cephalalgia",

issn = "0333-1024",

publisher = "SAGE Publications",

number = "1",

}

TY - JOUR

T1 - Improvement of the closed cranial window model in rats by intracarotid infusion of signalling molecules implicated in migraine

AU - Gupta, S

AU - Bhatt, D K

AU - Boni, L J

AU - Olesen, J

AU - Gupta, S

AU - Bhatt, D K

AU - Boni, L J

AU - Olesen, J

PY - 2010

Y1 - 2010

N2 - Intravital microscopy on a closed cranial window allows one to measure change in the diameter of cranial blood vessels after intravenous (i.v.) administration of pharmacodynamic substances. Putative targets being pursued in migraine are large vasodilating peptide molecules such as calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase polypeptide (PACAP)-38. High i.v. doses are required to study their craniovascular pharmacology. Unfortunately, this leads to a drop in blood pressure (BP) that subsequently causes blood vessels to dilate by autoregulation. Hence it is difficult to decipher what effect is caused by direct receptor agonist interaction or contributed by autoregulation. In the present study we infused substances with an ingenious indwelling catheter in the common carotid artery in rats. Intracarotidly seven-, 12- and 17-fold lower doses of CGRP, PACAP-38 and capsaicin were required, respectively, compared with i.v. infusion to induce the same dilation in dural artery. Dilating intracarotid (i.c.) doses caused no or a minimal fall in BP, whereas equi-responsive i.v. doses caused a marked BP reduction. The CGRP blocking potential of olcegepant was amplified by > 20 times on i.c. infusion. Pial artery responses to CGRP did not change with i.c. infusion, demonstrating that dilations after i.v. CGRP are mediated by autoregulation rather than through specific receptors. We applied CGRP topically, which induced concentration-dependent dural vasodilation, but no effect on pial artery or on BP. In conclusion, this new approach offers an improvement of the existing model by allowing more accurate assessment of effects of pharmaca on the cranial vasculature without inducing significant systemic effects.

AB - Intravital microscopy on a closed cranial window allows one to measure change in the diameter of cranial blood vessels after intravenous (i.v.) administration of pharmacodynamic substances. Putative targets being pursued in migraine are large vasodilating peptide molecules such as calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase polypeptide (PACAP)-38. High i.v. doses are required to study their craniovascular pharmacology. Unfortunately, this leads to a drop in blood pressure (BP) that subsequently causes blood vessels to dilate by autoregulation. Hence it is difficult to decipher what effect is caused by direct receptor agonist interaction or contributed by autoregulation. In the present study we infused substances with an ingenious indwelling catheter in the common carotid artery in rats. Intracarotidly seven-, 12- and 17-fold lower doses of CGRP, PACAP-38 and capsaicin were required, respectively, compared with i.v. infusion to induce the same dilation in dural artery. Dilating intracarotid (i.c.) doses caused no or a minimal fall in BP, whereas equi-responsive i.v. doses caused a marked BP reduction. The CGRP blocking potential of olcegepant was amplified by > 20 times on i.c. infusion. Pial artery responses to CGRP did not change with i.c. infusion, demonstrating that dilations after i.v. CGRP are mediated by autoregulation rather than through specific receptors. We applied CGRP topically, which induced concentration-dependent dural vasodilation, but no effect on pial artery or on BP. In conclusion, this new approach offers an improvement of the existing model by allowing more accurate assessment of effects of pharmaca on the cranial vasculature without inducing significant systemic effects.

U2 - 10.1111/j.1468-2982.2009.01888.x

DO - 10.1111/j.1468-2982.2009.01888.x

M3 - Journal article

C2 - 19438925

SN - 0333-1024

VL - 30

SP - 27

EP - 36

JO - Cephalalgia

JF - Cephalalgia

IS - 1

ER -